Overview
Charles Tiber is a Hematologist Oncology provider in Milwaukee, Wisconsin. His top areas of expertise are Castleman Disease, Multicentric Castleman Disease (MCD), Unicentric Castleman Disease (UCD), and Malignant Mixed Mullerian Tumor.
His clinical research consists of co-authoring 1 peer reviewed article and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years.
Specialties
Licenses
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
Cheruppolil Santhosh-Kumar is a Hematologist Oncology specialist and a Hematologist in Sheboygan, Wisconsin. Dr. Santhosh-Kumar is highly rated in 26 conditions, according to our data. His top areas of expertise are Angiosarcoma, Inflammatory Breast Cancer, Paget Disease of the Breast, and WT1-Related Wilms Tumor Syndromes.
Charles Bomzer is a Hematologist Oncology provider in Milwaukee, Wisconsin. Dr. Bomzer is highly rated in 6 conditions, according to our data. His top areas of expertise are Autoimmune Hemolytic Anemia, Hemangioma Thrombocytopenia Syndrome, Gastric Lymphoma, and Essential Thrombocythemia.
Ira Piel is a Hematologist Oncology provider in Gurnee, Illinois. His top areas of expertise are Chronic Lymphocytic Leukemia (CLL), Chronic B-Cell Leukemia (CBCL), Richter Syndrome, and Small Lymphocytic Lymphoma (SLL).
Frequently Asked Questions about Dr. Charles H. Tiber
How do I make an appointment with Dr. Charles H. Tiber?
You can book an appointment with Dr. Charles H. Tiber by calling their office at 414-298-7250. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Charles H. Tiber a top-rated expert for Castleman Disease?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Charles H. Tiber is classified as an Experienced expert for Castleman Disease, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Charles H. Tiber specialize in?
While Dr. Charles H. Tiber is a Hematology Oncology, they have specific expertise in Castleman Disease, Multicentric Castleman Disease (MCD), and Unicentric Castleman Disease (UCD). MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology Oncology.
Does Dr. Charles H. Tiber participate in research or clinical trials?
Yes. Dr. Charles H. Tiber has published 1 articles and abstracts on conditions like Castleman Disease. You can view a list of Dr. Charles H. Tiber's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Breast CancerDr. Tiber isExperienced. Learn about Breast Cancer.
- Castleman DiseaseDr. Tiber isExperienced. Learn about Castleman Disease.
- Follicular LymphomaDr. Tiber isExperienced. Learn about Follicular Lymphoma.
- Malignant Mixed Mullerian TumorDr. Tiber isExperienced. Learn about Malignant Mixed Mullerian Tumor.
- Multicentric Castleman Disease (MCD)Dr. Tiber isExperienced. Learn about Multicentric Castleman Disease (MCD).
- Ovarian CancerDr. Tiber isExperienced. Learn about Ovarian Cancer.